Clinical trials
Hip Fractures trials in Turkey (Türkiye) with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Başakşehir Çam & Sakura City Hospital | 3 |
| Ankara City Hospital Bilkent | 2 |
| Medipol University | 2 |
| Saglik Bilimleri Universitesi Gulhane Tip Fakultesi | 2 |
| Umraniye Education and Research Hospital | 2 |
| Akdeniz University | 1 |
| Antalya Training and Research Hospital | 1 |
| Bozyaka Training and Research Hospital | 1 |
| Cigli Regional Training Hospital | 1 |
| Cukurova University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hip Fractures | 31 |
| Postoperative Pain | 11 |
| Agnosia | 7 |
| Femoral Neck Fractures | 3 |
| Hip Injuries | 3 |
| Acute Pain | 2 |
| Pain | 2 |
| Bone Diseases, Metabolic | 1 |
| Delirium | 1 |
| Embolism and Thrombosis | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.